The latest update is out from Innoveren Scientific (IVRN).
Innoveren Scientific, Inc. has struck a deal with an accredited investor, selling 400,000 shares and an equal number of warrants at $0.50 each, resulting in $100,000 of gross proceeds. This transaction, leveraging exemptions under the Securities Act, aims to bolster the company’s financial position without the need for a traditional public offering.
See more insights into IVRN stock on TipRanks’ Stock Analysis page.
